Table 2.
Non–COVID‐19 (n = 52) | COVID‐19 (n = 52) | P value | |
---|---|---|---|
Prone mech. vent., n | 1 | 42 | <0.0001 |
Length of proning, median (IQR), days | 0 (0–0) | 3 (1–5.8) | <0.0001 |
Myorelaxants, n | 39 | 51 | <0.0001 |
Length, median (IQR), days | 4 (2–7) | 9 (6–12) | <0.0001 |
High GRV (>500 ml/day), n (%) | 15 (29) | 23 (44) | 0.102 |
Length, median (IQR), days | 2 (1–4) | 2 (2–4) | 0.934 |
Bowel activity on days 1–10 (total 1035 days), n | 514 | 515 | 0.453 |
Constipation, n (%) | 308 (59.2) | 321 (62.3) | NS |
Enema fluid, n | 17 | 22 | |
Diarrhea, n (%) | 106 (20.6) | 105 (20.4) | |
Normal, n (%) | 83 (16.2) | 67 (13.0) | |
Bowel activity on days 11–30 (total 1314 days), n | 732 | 593 | 0.0005 |
Constipation, n (%) | 249 (34.0) | 214 (36.1) | |
Enema fluid, n | 23 | 14 | |
Diarrhea, n (%) | 244 (33.3) | 143 (23.9) | |
Normal, n (%) | 216 (29.5) | 223 (37.6) |
Abbreviations: COVID‐19, coronavirus disease 2019; GRV, gastric residual volume; mech. vent., mechanical ventilation; NS, not significant.